Pharmaceutics

The Diversion of Drugs Within Healthcare Needs to be Addressed

$183M Lost Due to Healthcare Workforce Diverting Drugs From Patient Care in 2019

The Protenus Drug Diversion Digest found that over half of diversion incidents took place in a hospital, medical center, or physician practice setting

BALTIMORE, Sept. 15, 2020 /PRNewswire/ — Protenus, a healthcare compliance analytics platform that detects anomalous behavior in our nation’s health systems, announced new research about the effects of drug diversion on healthcare organizations, providers, and patients. With this information, organizations can understand how to prevent diversion, while identifying and supporting workforce members with substance abuse disorders and protecting patients from harm.

The 2020 Drug Diversion Digest is the only report of its kind to compile and analyze publicly available data on clinical drug diversion incidents involving healthcare workers. As found in the report, the average fine to diverters in 2019 was $575,000.

Drug diversion is the transfer of a controlled substance from a lawful to an unlawful channel of distribution or use. Examples of this include a nurse stealing pills from a nursing home or a physician writing fraudulent prescriptions. In especially contemptible cases, clinicians have tampered with syringes that contain controlled substances for their own use, potentially exposing patients to infectious disease or failing to adequately treat their pain.

When comparing 2019 data to that of 2018, the number of reported incidents decreased by almost 36%. However, there was a 215% increase in total doses lost, from 47M in 2018 to 148M in 2019.  

“This data is just the tip of the iceberg in understanding the full scope of drug diversion in healthcare. With current methods of drug diversion monitoring, pharmacy or compliance teams are only able to react to incidents that are brought to their attention, often after a devastating event has occurred,” said Nick Culbertson, Co-founder and CEO of Protenus. “The technology now exists with healthcare compliance analytics to enable health systems to detect early warning signs of possible diversion and prevent future incidents from occurring, reducing risk across the organization and protecting patients and workforce members from potential harm.” 

To download the 2020 Drug Diversion Digest, please visit: Protenus

About Protenus

Protenus uses AI to reduce risk and save resources for the nation’s leading health systems, detecting and preventing compliance violations such as breaches to patient privacy and incidents of clinical drug diversion. Compliance analytics provide healthcare leaders full insight into how health data is being used and alerts privacy, pharmacy, and compliance teams to inappropriate activity. Protenus helps our partner hospitals make decisions about how to better protect their data, their patients, and their institutions. This year, Protenus was named the 2020 KLAS Category Leader in Patient Privacy Monitoring, one of Forbes’ Best Startup Employers in 2020, and one of The Best Places to Work in Healthcare by Modern Healthcare. Learn more at Protenus.com.

Media Contact:Kira Caban

kira@protenus.com

SOURCE Protenus

Medika Life

Medika Life is a digital Health Publication for both the medical profession and the public. Make informed decisions about your health and stay up to date with the latest developments and technological advances in the fields of medicine.

Recent Posts

From AI Excitement to Execution: Why Health Leaders Must Now Master the “How”

Artificial intelligence is advancing in health care faster than almost any other technology in modern…

1 day ago

The Shift from Pure Modernity to Human-Centered Modernity

Throughout the history of science, it has rarely been the case that any phenomenon has…

1 day ago

We Have to Earn Better Vaccine Coverage Rates

Mandates and strong recommendations have been the key to successful vaccination programmes protecting people for…

1 day ago

Brain Organoids: Promise, Limits, and What Comes Next

Brain organoids, sometimes called “mini-brains,” are three-dimensional clusters of human brain cells grown in labs from pluripotent stem…

1 day ago

How Transactional Medicine Threatens the Future of Your Health

Patients rarely describe healing in technological terms. They speak instead about whether someone listened, if…

6 days ago

Is Your LLM Mentor Human Enough?

In every professional and personal sphere—be it business, medicine, engineering, or parenting—we inherently need a…

3 weeks ago

This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.

Read More